These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Natural killers and macrophages: their activity in leukemias]. Fi FT Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945 [No Abstract] [Full Text] [Related]
24. An introduction to tumour immunology. James K Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141 [TBL] [Abstract][Full Text] [Related]
25. The influence of histamine on immune and inflammatory responses. Beer DJ; Matloff SM; Rocklin RE Adv Immunol; 1984; 35():209-68. PubMed ID: 6235726 [No Abstract] [Full Text] [Related]
27. Autocytotoxic activity of lymphokine-activated killer cells: characterization of effector cells and susceptible targets. Suzuki H; Ikemoto M; Kamitani T; Hoshino K; Yano S Anticancer Res; 1989; 9(2):293-7. PubMed ID: 2568770 [TBL] [Abstract][Full Text] [Related]
28. Frequency determination of killer cells by a single-cell cytotoxic assay. Bonavida B; Bradley TP; Grimm EA Methods Enzymol; 1983; 93():270-80. PubMed ID: 6408349 [No Abstract] [Full Text] [Related]
29. Antibacterial activity against Streptococcus pneumoniae by mouse lung lymphocytes. Sestini P; Nencioni L; Villa L; Boraschi D; Tagliabue A Adv Exp Med Biol; 1987; 216A():517-25. PubMed ID: 3500582 [No Abstract] [Full Text] [Related]
30. Intratumor host cells of experimental rat neoplasms: characterization and effector function. Moore M; Moore K Contemp Top Immunobiol; 1980; 10():109-42. PubMed ID: 6967795 [No Abstract] [Full Text] [Related]
31. Cell-mediated immune reactions to human tumors. Perlmann P; Troye M; Pape GR Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485 [No Abstract] [Full Text] [Related]
33. Induction of the differentiation of memory T killer cells with factors released from macrophage-like cell lines. Igarashi T; Ikeda Y; Saito H; Takano S; Kishimoto T; Shida T Cell Immunol; 1982 Jun; 70(1):11-26. PubMed ID: 6981462 [No Abstract] [Full Text] [Related]
34. In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. Tani M; Tanimura H; Yamaue H; Iwahashi M; Tsunoda T; Tamai M; Noguchi K; Arii K Eur J Clin Pharmacol; 1992; 42(6):623-7. PubMed ID: 1623902 [TBL] [Abstract][Full Text] [Related]
35. Recognition and destruction of neoplastic cells by activated macrophages: discrimination of altered self. Fidler IJ; Schroit AJ Biochim Biophys Acta; 1988 Nov; 948(2):151-73. PubMed ID: 3052591 [No Abstract] [Full Text] [Related]
38. [Cytotoxic cells of the NK type - their characteristics and role in anti-neoplastic immunity]. Janiak M; Lipski S Postepy Hig Med Dosw; 1982; 36(1-3):95-131. PubMed ID: 6763997 [No Abstract] [Full Text] [Related]
39. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells. Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741 [TBL] [Abstract][Full Text] [Related]
40. Host-tumor interactions in immunosurveillance against cancer. Urban JL; Schreiber H Prog Exp Tumor Res; 1988; 32():17-68. PubMed ID: 3287449 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]